← Leaderboards
Todd R. Golub
Dana-Farber Cancer Institute
$52,404,583
Attributed
$66,711,177
Total exposure
22
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.8M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$90,871,758 · 23
By mechanism
U54$55,924,375 · 4
RL1$9,913,569 · 1
R35$6,896,753 · 1
U01$5,996,590 · 2
P01$4,910,986 · 7
R01$3,536,235 · 2
Top collaborators
- Aravind Subramanian15 shared
- William C Hahn4 shared
- David Thomas4 shared
- Wendy Winckler4 shared
- Bruce E. Johnson1 shared
- Nancy E. Kohl1 shared
Most similar at Dana-Farber Cancer Institute
Same institution · by research overlap
- Thomas M Roberts$29,815,975
- William C Hahn$46,384,528
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseProgramsBiologicalGenesPathway InteractionsGenomicsMapsCommunitiesGene ExpressionGeneticInsightSmall MoleculeGene Expression ProfileBiologyResearch PersonnelNovel StrategiesGenerationsMalignant NeoplasmsPharmaceutical PreparationsCostMolecular ProfilingSamplingTumorInstitutes
Grant awards (101)
Making cancer precision medicine real: bottlenecks and opportunities$1,023,754
R35 · FY2025 · CA · contact PI
Making cancer precision medicine real: bottlenecks and opportunities$972,460
R35 · FY2024 · CA · contact PI
Making cancer precision medicine real: bottlenecks and opportunities$1,003,799
R35 · FY2023 · CA · contact PI
Making cancer precision medicine real: bottlenecks and opportunities$1,003,803
R35 · FY2022 · CA · contact PI
Making cancer precision medicine real: bottlenecks and opportunities$844,357
R35 · FY2021 · CA · contact PI
Discovering existing medicines that abrogate cellular responses to SARS CoV-2 infection$1,652,790
U54 · FY2020 · HL · contact PI
Making cancer precision medicine real: bottlenecks and opportunities$1,024,290
R35 · FY2020 · CA · contact PI
Broad Institute LINCS Center for Transcriptomics$2,108,141
U54 · FY2019 · HL · contact PI
Making cancer precision medicine real: bottlenecks and opportunities$1,024,290
R35 · FY2019 · CA · contact PI
LINCS Data Coordination and Integration Center$500,000
U01 · FY2019 · HG · contact PI
Broad Institute LINCS Center for Transcriptomics$28,061
U54 · FY2019 · HL · contact PI
Broad Institute LINCS Center for Transcriptomics$2,107,754
U54 · FY2018 · HL · contact PI
LINCS Data Coordination and Integration Center$668,817
U01 · FY2018 · HG · contact PI
Clinical implementation of single cell tumor transcriptome analysis$438,253
R33 · FY2018 · CA · contact PI
Broad Institute LINCS Center for Transcriptomics$2,107,379
U54 · FY2017 · HL · contact PI
LINCS Data Coordination and Integration Center$668,817
U01 · FY2017 · HG · contact PI
PQB-3: Discovery and validation of the driving mediators of cancer cachexia$585,575
R01 · FY2017 · CA · contact PI
Broad Institute LINCS Center for Transcriptomics$2,107,014
U54 · FY2016 · HL · contact PI
The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center$698,459
U01 · FY2016 · CA
LINCS Data Coordination and Integration Center$668,817
U01 · FY2016 · HG · contact PI
PQB-3: Discovery and validation of the driving mediators of cancer cachexia$620,997
R01 · FY2016 · CA · contact PI
Broad Institute LINCS Center for Transcriptomics$2,092,758
U54 · FY2015 · HL · contact PI
The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center$703,315
U01 · FY2015 · CA
LINCS Data Coordination and Integration Center$668,817
U01 · FY2015 · HG · contact PI
PQB-3: Discovery and validation of the driving mediators of cancer cachexia$615,301
R01 · FY2015 · CA · contact PI
Broad Institute Center for Cancer Systems Biology$2,106,778
U54 · FY2014 · CA · contact PI
Broad Institute Center for Cancer Systems Biology$2,106,778
U54 · FY2014 · CA · contact PI
Broad Institute LINCS Center for Transcriptomics$2,092,758
U54 · FY2014 · HL · contact PI
The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center$693,679
U01 · FY2014 · CA
PQB-3: Discovery and validation of the driving mediators of cancer cachexia$554,405
R01 · FY2014 · CA · contact PI
Large scale gene expression analysis of cellular states$2,444,991
U54 · FY2013 · HG · contact PI
Broad Institute Center for Cancer Systems Biology$2,006,126
U54 · FY2013 · CA · contact PI
Broad Institute Center for Cancer Systems Biology$2,004,265
U54 · FY2013 · CA · contact PI
The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center$725,869
U01 · FY2013 · CA
Broad Institute Center for Cancer Systems Biology$68,730
U54 · FY2013 · CA · contact PI
Broad Institute Center for Cancer Systems Biology$68,730
U54 · FY2013 · CA · contact PI
Large scale gene expression analysis of cellular states$62,764
U54 · FY2013 · HG · contact PI
Large scale gene expression analysis of cellular states$2,336,931
U54 · FY2012 · HG · contact PI
Broad Institute Center for Cancer Systems Biology$2,155,526
U54 · FY2012 · CA · contact PI
Broad Institute Center for Cancer Systems Biology$2,155,481
U54 · FY2012 · CA · contact PI
Molecular Signatures of Melanoma: Predicting Response to Therapy & Targeting$239,292
P50 · FY2012 · CA · contact PI
Large scale gene expression analysis of cellular states$204,194
U54 · FY2012 · HG · contact PI
Large scale gene expression analysis of cellular states$120,000
U54 · FY2012 · HG · contact PI
Large scale gene expression analysis of cellular states$100,000
U54 · FY2012 · HG · contact PI
Broad Institute Center for Cancer Systems Biology$44,814
U54 · FY2012 · CA · contact PI
Broad Institute Center for Cancer Systems Biology$44,814
U54 · FY2012 · CA · contact PI
Large scale gene expression analysis of cellular states$2,322,558
U54 · FY2011 · HG · contact PI
Broad Institute Center for Cancer Systems Biology$2,032,718
U54 · FY2011 · CA · contact PI
Broad Institute Center for Cancer Systems Biology$2,032,718
U54 · FY2011 · CA · contact PI
Discovery Pipeline (2 of 4)$1,791,784
RL1 · FY2011 · CA · contact PI
Molecular Signatures of Melanoma: Predicting Response to Therapy & Targeting$271,316
P50 · FY2011 · CA · contact PI
Genomics and Bioinformatics$261,821
P01 · FY2011 · CA · contact PI
Large scale gene expression analysis of cellular states$88,425
U54 · FY2011 · HG · contact PI
Broad Institute Center for Cancer Systems Biology$2,222,285
U54 · FY2010 · CA · contact PI
Discovery Pipeline (2 of 4)$2,002,422
RL1 · FY2010 · CA · contact PI
Large scale gene expression analysis of cellular states$1,372,584
U54 · FY2010 · HG · contact PI
Connectivity Map 100k$968,711
RC2 · FY2010 · HG · contact PI
Genomics and Bioinformatics$393,681
P01 · FY2010 · CA · contact PI
Molecular Signatures of Melanoma: Predicting Response to Therapy & Targeting$282,401
P50 · FY2010 · CA · contact PI
Genomics and Bioinformatics$270,100
P01 · FY2010 · CA · contact PI
Anti-ALL Small Molecular Discovery via Chemical Genomics$246,880
P01 · FY2010 · CA · contact PI
Discovery Pipeline (2 of 4)$2,077,702
RL1 · FY2009 · CA · contact PI
Signatures of Kinase Activation in Cancer$1,212,349
U54 · FY2009 · CA · contact PI
Connectivity Map 100k$967,265
RC2 · FY2009 · HG · contact PI
Genomics and Bioinformatics$388,748
P01 · FY2009 · CA · contact PI
Molecular Signatures of Melanoma: Predicting Response to Therapy & Targeting$282,142
P50 · FY2009 · CA · contact PI
Genomics and Bioinformatics$264,977
P01 · FY2009 · CA · contact PI
Anti-ALL Small Molecular Discovery via Chemical Genomics$242,062
P01 · FY2009 · CA · contact PI
Signatures of Kinase Activation in Cancer$82,200
U54 · FY2009 · CA · contact PI
Discovery of inhibitors of anti-apoptotic protein A1$25,000
R03 · FY2009 · DA · contact PI
Signatures of Kinase Activation in Cancer$2,423,919
U54 · FY2008 · CA · contact PI
Discovery Pipeline (2 of 4)$2,074,448
RL1 · FY2008 · CA · contact PI
Genomics and Bioinformatics$326,494
P01 · FY2008 · CA · contact PI
Genomics and Bioinformatics$258,080
P01 · FY2008 · CA · contact PI
Anti-ALL Small Molecular Discovery via Chemical Genomics$235,053
P01 · FY2008 · CA · contact PI
Molecular Signatures of Melanoma: Predicting Response to Therapy & Targeting$218,870
P50 · FY2008 · CA · contact PI
Signatures of Kinase Activation in Cancer$2,402,208
U54 · FY2007 · CA · contact PI
Discovery Pipeline (2 of 4)$1,967,213
RL1 · FY2007 · CA · contact PI
Functional Genomic Dissection of Refractory Anemia$418,384
R01 · FY2007 · HL · contact PI
Genomics and Bioinformatics$317,264
P01 · FY2007 · CA · contact PI
Genomics and Bioinformatics$259,206
P01 · FY2007 · CA · contact PI
Anti-ALL Small Molecular Discovery via Chemical Genomics$232,755
P01 · FY2007 · CA · contact PI
Signatures of Kinase Activation in Cancer$2,404,193
U54 · FY2006 · CA · contact PI
Functional Genomic Dissection of Refractory Anemia$419,371
R01 · FY2006 · HL · contact PI
Genomics and Bioinformatics$308,264
P01 · FY2006 · CA · contact PI
Anti-ALL Small Molecular Discovery via Chemical Genomics$173,551
P01 · FY2006 · CA · contact PI
Signatures of Kinase Activation in Cancer$10,841
U54 · FY2006 · CA · contact PI
Signatures of Kinase Activation in Cancer$2,530,580
U54 · FY2005 · CA
Functional Genomic Dissection of Refractory Anemia$322,202
R01 · FY2005 · HL
Signatures of Kinase Activation in Cancer$2,459,220
U54 · FY2004 · CA
Core--DNA microarray and bioinformatics$103,677
P01 · FY2002 · CA
Genomic expression analysis of tumors after radical prostatectomy$0
P50 · FY2002 · CA
Core--Genomics$0
P50 · FY2002 · CA
CORE--DNA MICROARRAY AND BIOINFORMATICS$0
P01 · FY2002 · CA
GENOMIC PREDICTOR OF ACUTE LYMPHOCYTIC LEUKEMIA BIOLOGY$0
P01 · FY2002 · CA
CHARACTERIZATION OF TEL, A NEW LEUKEMOGENIC ETS PROTEIN$279,549
P01 · FY2001 · CA
CORE--DNA MICROARRAY AND BIOINFORMATICS$0
P01 · FY2001 · CA
Core--DNA microarray and bioinformatics$0
P01 · FY2001 · CA
GENOMIC PREDICTOR OF ACUTE LYMPHOCYTIC LEUKEMIA BIOLOGY$0
P01 · FY2001 · CA
CHARACTERIZATION OF TEL, A NEW LEUKEMOGENIC ETS PROTEIN$348,824
P01 · FY2000 · CA
GENOMIC PREDICTOR OF ACUTE LYMPHOCYTIC LEUKEMIA BIOLOGY$0
P01 · FY2000 · CA